Indian censors have banned an award-winning documentary that chronicles one of the country's most painful and deadly episodes of Hindu-Muslim violence. \nFinal Solution is scheduled for release in 40 art house cinemas in Germany next month, where it won an award at this year's Berlin Film Festival. But in India, the Central Board of Film Certification has refused public screening of the film, saying it might trigger more sectarian violence. \nFilmmaker Rakesh Sharma said on Friday he would approach the Mumbai High Court to challenge the board's ruling. \n"I will be going straight to court," Sharma told reports about his feature-length movie that records the 2002 religious rioting in the western state of Gujarat, which killed more than 1,000 people, most of whom were Muslims. \nThe riots broke when Hindu mobs set off a wave of revenge killings after the burning of a train that left 60 Hindus dead. \nThe attack was blamed on Muslims, but investigators have not been able to confirm that. \nSharma's movie weaves in speeches of Hindu nationalists with interviews of rioters and victims. The censor board said the documentary was "highly provocative and may trigger off unrest and communal violence." \n"People who make hate speeches should be banned and not the filmmaker who records it," Sharma said. \nThe 210-minute movie won two awards at this year's Berlin Film Festival and one award at the Hong Kong festival. It wasn't allowed a screening in Singapore during the city-state's film festival in May, after its censor board deemed it "potentially inflammatory." \nOne chilling episode in the film shows a 4-year-old Muslim boy, named Ijaz, detailing in a singsong voice how he saw his grandfather and aunt being killed. \nIn the final scene, he recites his multiplication tables and then says in a calm voice he would kill Hindus, "because they did the same."
UNCERTAINTY: US Secretary of State Antony Blinken did not specify measures NATO might take, but many believe that the Nord Stream 2 pipeline project could be canceled The US has said it has evidence that Russia has made plans for a “large scale” attack on Ukraine and said NATO allies are “prepared to impose severe costs” on Moscow if it attempts an invasion. Speaking at a NATO ministers meeting in Latvia, US Secretary of State Antony Blinken said that it was unclear whether Russian President Vladimir Putin had made a decision to invade, but added: “He’s putting in place the capacity to do so in short order, should he so decide.” “So despite uncertainty about intention and timing, we must prepare for all contingencies while working to see to
‘TRAVEL APARTHEID’: Biden’s top medical adviser said the US was considering lifting restrictions on travel from African nations imposed after the variant was discovered The Omicron variant of SARS-CoV-2 is rapidly spreading throughout the US, but early indications suggest it might be less dangerous than the Delta variant, which continues to drive a surge of hospitalizations, US health officials said on Sunday. US National Institute of Allergy and Infectious Diseases Director Anthony Fauci told CNN’s State of the Union that scientists need more information before drawing conclusions about Omicron’s severity. Reports from South Africa, where it emerged and is becoming the dominant strain, suggest that hospitalization rates have not increased alarmingly. “Thus far, it does not look like there’s a great degree of severity to it,” Fauci
HOPEFUL: ‘We found a really good immune response across the board,’ even higher than with two doses of the AstraZeneca vaccine, the study’s lead author said A major British study on mixing COVID-19 vaccines has found that people had a better immune response when they received a first dose of the AstraZeneca or Pfizer-BioNTech vaccines followed by the Moderna vaccine nine weeks later, the results showed on Monday. “We found a really good immune response across the board ... in fact, higher than the threshold set by two doses of the Oxford-AstraZeneca vaccine,” said Matthew Snape, the University of Oxford professor behind the trial dubbed Com-COV2. The findings supporting flexible dosing offer some hope to poor and middle-income countries that might need to combine different brands between the
South African hospitals are bracing for a surge in admissions as the Omicron variant of SARS-CoV-2 drives a sharp rise in COVID-19 infections and as more evidence emerges about the severity of the illness caused by the strain. The seven-day moving average of daily new cases in the country rose to 10,055 last week, from fewer than 300 three weeks earlier. Hospitalizations also picked up, but remain relatively low, with admissions standing at 3,268 on Sunday. Whether there would be a deluge of new patients is the biggest question. Severe symptoms in patients who contracted earlier variants typically developed between one and three